depart justic approv cigna-express deal merger
updat forecast estim oct
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research sep
estim oct
price data oct
rate updat oct
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
managed-car sector driven turbul
past five year dynam like major factor
next sever year result made major strateg
move acquir largest independ pharmaci benefit
manag express script order posit long-term
success oper believ great strateg move
acquir wide-moat healthcar player
servic grow ever critic next sever
year also believ managed-car firm pay fair price
consid potenti synergi deal like add
materi sharehold valu
independ health insur busi potenti
develop moat given larg membership base howev
capit asset usag disabl life reinsur
supplement insur line signific drag firm-wide
return invest capit leav disadvantag
face seismic industri chang believ industri
encompass significantli greater degre transpar
competit cost
backdrop believ firm decis merg
express script correct move perspect
combin entiti benefit superior client member
manag central cost scale advantag
diversifi busi model deal expect close toward
end expect moder regulatori
pushback histor feder govern
favor upon pbm deal approv similarli larg
acquisit purchas catamaran
fact combin govern extens pbm
contract employe health insur plan give us
confid cigna/express script merger like
approv justic depart believ deal offer
firm opportun drive value-cr synergi give
enhanc servic portfolio compet unitedhealth
potenti cvs/aetna tie-up
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
one largest managed-car organ unit state
littl million medic member firm provid health
insur servic individu mainli group employ
market one leader commerci self-fund fee market
good portion growth continu come
large-group cohort firm made bid acquir express
script would make largest pharmaci benefit manag
billion prescript claim process annual
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
depart justic approv cigna-express deal
despit signific effort pharmaci market
particip investor scuttl deal
depart justic recent approv merger
express script littl pushback
develop fall line expect
factor chanc doj approv deal
analysi firm thu maintain
fair valu estim
respect addit maintain no-moat
wide moat rate managed-car
organ pharmaci benefit manag respect
howev plan updat fair valu moat rate
fulli incorpor outlook
combin entiti expect deal offici close
end year full integr
perspect new firm one
strongest healthcar market combin
sizabl wide-moat pbm
form power busi oper new entiti
formid forc abl wield signific
price power leverag top-tier scale advantag
believ opportun build
power busi integr wide-moat pbm
oper
solid busi
perspect new combin firm possess strong
foundat expand servic increas cross-
sale ultim enhanc competit posit
firm holist insur option new
healthcare-servic compani abl offer client
give flexibl sell prospect
anticip help
win new busi
addit new conglomer also abl
leverag busi better input price
pharmaceut medic servic -- allow solid
plan price lower overal cost structur per member
increas fair valu estim
per share firm process tri
close propos acquisit express script overal
believ deal offer firm opportun
drive value-cr synergi result enhanc
servic portfolio compet
potenti cvs/aetna tie-up deal expect close
toward end expect moder
regulatori pushback
histor feder govern look favor
upon pbm deal recent approv similarli larg
acquisit purchas catamaran
fact combin govern extens
pbm contract employe health insur plan
give us confid cigna/express script merger
like approv justic depart
build combin valuat model believ
excel top- bottom-lin synergi
opportun cigna/express script entiti new
firm would extrem power player healthcar
formid player economi
explicit forecast period believ cigna/express
script abl win busi expand
membership good clip addit believ
enhanc member treatment manag capabl
combin mco/pbm model allow slightli lower
medic loss increas formulari power ad
posit factor abil elimin redund
admin activ central cost
factor pro forma revenu growth rate
averag oper margin assum new
firm abl increas overal membership off-set
expect loss anthem pbm claim gain
intern cigna pbm claim least preserv profit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
govern becom even punit toward
industri place greater pressur industri player
scenario assum neg premium growth
greater competit higher due stringent
govern regul stagnant membership growth
less posit scale factor sg expens also
factor major issu relat integr express
script asset scenario fair valu estim
decreas
believ moat achiev industri
build sizabl membership base solid provid
network larger nation managed-car organ
scale fix cost nonmed servic expens across
larg member base posit advantag
smaller region peer larger mco also gain
popul underwrit expertis help price
risk plan appropri preserv return
obtain robust member network yield
also ensur necessari medic servic
provid improv medic cost premium growth
lastli mild network effect creat ampl
membership base provid option
construct flexibl provid network turn
allow creat greater number product
even though believ core insur busi
potenti moati stand-alon basi
vari book insur segment prevent us
assign econom moat non-health-insur
oper siphon capit human resourc asset
solid managed-car oper perspect
also serv distract manag attent
mani insur line also deliv synergi
could detract valu roic materi lower
margin effici gain
scenario analysi take consider
variabl incorpor chang premium growth
rate medic loss ratio membership growth sell
gener administr expens scale also factor
effect potenti express script acquisit
bull-cas scenario factor slightli posit
premium growth consolid medic loss ratio
slightli lower base-cas assumpt
increas membership growth commerci risk
busi greater sg cost scale scenario
believ exchang market less catalyst
greater industri transpar competit
addit assum secular trend large-group
custom migrat fee-bas plan slow moder
final factor near flawless integr
express script asset drive value-cr
versu value-destruct scenario fair valu
estim increas
bear-cas scenario assum feder
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
lower profit addit minimum medic loss
ratio effect cap gross profit
major market pressur capit return ad
pressur uncertainti relat futur health
insur market given strong push republican
parti significantli rework materi portion
major materi oper depend
govern fund -- medicar medicaid dual-elig
growth privat public medic program
oper look upon major growth driver
come year howev profit
membership cohort significantli lower lucr
fulli insur employ busi drove signific
growth base health insur
industri face materi greater degre
transpar shift certain advantag insur
consum competit increas mco seek
build exchang oper augment
commerci membership greater regul gross
profit cap certain product add industri
headwind give mco major growth
opportun growth come lower profit
peer insur made strong push
move intern market believ
competit advantag weak -base mco
believ littl leverag oper
vari busi togeth need skill expert staff
execut sell underwrit mainten
claim process variou product insur
backdrop believ made
value-cr strateg move propos merger
express script believ express script built wide
econom moat substanti claim volum give
opportun take advantag two key industri driver
leverag unmatch
central cost scale total adjust claim
approxim billion pbm negoti favor
drug price supplier factor give
advantag expand client base provid low-cost
product time preserv gross
margin scale also sourc competit advantag
addit claim process profit
previou central cost abl spread across
entir level claim clearli give advantag
larger pbm result factor express script
produc top-tier gross oper profit per adjust
claim believ benefit
believ five major mco cover neg
moat trend volatil legisl landscap
growth come lower-profit insur cohort
oper environ mco significantli
pressur long term industri
encompass much greater degre transpar
competit expand healthcar coverag give
mco major growth opportun growth come
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
owith potenti acquisit express script
opportun posit one
advantag power player
oth firm one market leader commerci
self-fund fee market
growth origin large-group insur
owe believ healthcar insur line
sizabl membership base give competit
oif cigna fail close propos express script
acquisit difficult long-term posit
compar peer
oth firm su former merger partner
countersu damag
unfavor rule could
vari insur line hindranc
lack synergi among busi build
good amount ineffici
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
current balanc sheet easili manag
last count debt stood billion roughli time
ebitda give firm plenti room use good
amount leverag acquisit express script
manag expect debt level increas billion
post merger includ assumpt billion
outstand debt express script accord
manag push debt/capit ratio
expect repay debt steadi clip move
ratio back around within month
deal close given strong free cash flow gener
entiti believ goal achiev
uncertainti encapsul industri thick
legisl environ provid possibl
forward addit space experienc trend
toward vertic integr major mco either
acquir partner provid pbm
vendor outdon made bid acquir
express script largest pbm integr
highli complex busi carri materi risk
merger administr system sales/cli support
oper busi activ could take
extend period less optim independ
face sever risk navig decreas
payment rate government-sponsor medic program
add heighten uncertainti mco
especi true signific amount
revenu tie non-healthcar insur product
vari insur market firm compet creat
materi amount uncertainti segment
synergi addit capit asset usag
individu busi requir add element risk
oper mco may deal
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
repres date owner name posit common share held report holder issuer
find manag abil improv prospect
face major headwind highli impress
compani abl expand membership materi
still keep medic cost
expect past year offset solid
perform core oper sever
insur line addit firm manag
balanc sheet question ran seriou liquid
issu econom downturn howev
manag move merg express script
major posit perspect allow
firm opportun improv competit posit
deal allow close
share
fund
share
fund
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
believ cigna-express merger major posit
concern certain pharmaci market
particip investor see cigna-express script
merger hold sever strateg posit market
concern recent highlight wall street
journal report said well-known activist investor
accumul sizabl equiti stake describ less
outstand equiti stock plan vote
deal base concern relat increas
competit amazon potenti increas
govern intervent relat drug price
weight issu may believ
specif gener market concern base
reiter posit outlook combin compani
believ new entiti formid forc
healthcar abl wield signific price
power leverag major scale advantag expect
abl build power busi
merger enhanc current no-moat rate
gain strong foundat expand
servic cross-sal wide moat given discount
trade stand-alon fair valu
estim approxim offer price
believ investor opportun acquir share
strong wide-moat healthcar servic player materi
discount addit reiter fair valu
estim
valu servic receiv
would also note major client
larg sophist insur compani employ
government-sponsor program usual
pbm contract audit consult annual thu
vast major client know exact financi
oper dynam relationship pbm
chosen renew servic fact
direct counter mani drug market stakehold concern
extract exorbit amount valu
client
nevertheless mani investor question cigna
motiv strategi concern relat viabil
pbm busi model believ concern
prescript claim make largest pbm unit
state give approxim market share
mean one fourth prescript
manag dynam give firm two
key advantag -- superior supplier price leverag
central cost scale -- merger
address top-of-mind concern
investor relat busi model
brand rebat flow client
firm report strong second-quart result
believ show busi perform solid level
reinforc posit outlook cigna-express
healthcar servic behemoth would highlight
increas expect client retent rate
outlook boost
strong sell season pharmaci benefit manag
opinion point base client see
make profit brand rebat
client dictat pbm compens
choos much brand rebat pass
certain case client pass specif
percentag rebat lieu fee
mani case client ask rebat dollar pass
compens fee
increas spread retent gener discount fact
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
report rebat dollar
discount pass client
would also highlight gener fill rate
percentag prescript gener
pbm peer increas significantli past
decad move less earli
close today
detail analysi relat brand rebat
estim breakdown profit
discount tool pleas see novemb report
price drug middlemen clarifi price
overal cost pharmaceut significantli lower
express script client
report drug trend metric
incorpor price util first half
well nation averag
track eclips alreadi low mark compar
favor high-single-digit growth drug cost
 experienc past sever year firm
also mention use drug plan manag
program steadili increas believ
major contribut factor impress trend run
rate lock client firm servic
potenti competit amazon doomsday
specul amazon disrupt pharmaceut
space leverag impress capit war chest
custom servic expertis caus great concern
viabil pbm howev unlik market
reli demand/suppli cycl healthcar space driven
reimburs compens system predic upon risk-
base insur underwrit addit believ mani
analyst miss key point true end custom space
consum drug rather insur
employ govern pay health benefit
consum accordingli expertis need
profit navig space preclud easi entranc
arena believ amazon lack expertis
may find advantag ventur health
insur underwrit see three key variabl
overlook market particip
stakehold analyz potenti new meaning
competit pharmaceut market
true custom along chain busi
provid health benefit consum provid
health benefit make almost decis regard drug
pharmaci access busi also sourc suppli
drug partnership btob market
develop use drug health insurance-
base treat medic ailment consum demand
cash-pay market estim less
prescript paid consum directli cash-
pay basi without insur dynam would take
mani consumer-bas compani built
success consum demand-driven market outsid
core compet get involv
pharmaceut space
 price pharmaceut
market particip believ amazon instantli
enter space cut price drug product right away
howev actual price drug alreadi low given
massiv amount buy power pbm drug
wholesal retail pharmaci accumul
new entrant would hold minuscul amount purchas
power compar massiv joint sourc ventur
develop last hand year thu
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
level gener drug discount brand drug rebat
new entrant could command would pale comparison
major pharma suppli chain player make
difficult price-competit
 access global suppli drug requir
viabl player pbm space access everi
legitim drug requir relationship retail
pharmaci drug manufactur due variabl
demand health insur product viabl pbm
player need access plethora drug
manufactur across world level access
alreadi achiev major drug market servic
player new entrant reach level
option clear major drug benefit provid
seller purchas pharmaceut
detail analysi competit dynam
pharmaceut space amazon potenti
disrupt pleas see decemb report sell
drug easier said done moati pharma
despit amazon acquisit pillpack market
june amazon announc purchas mail-ord
pharmaci start-up pillpack move give amazon
foothold within pharmaceut suppli chain
logic step on-line conglomer make
believ retail pharmaci go easiest
segment pharmaceut suppli chain amazon
enter howev also believ still tough
firm creat major disrupt within healthcar
space given insur dynam drive market
perspect new competitor need deal
larg power custom despit
market particip believ true end custom
pharmaceut space consum drug
rather insurer/employer/govern pay
health benefit consum accordingli expertis
need profit navig space preclud easi
opportun new entrant believ current
downward stock price move fear new disrupt
competit drug space creat opportun
investor acquir solid moati firm drug wholesal
pbm industri discount
perspect three key variabl
overlook market particip
stakehold analyz potenti new meaning
competit within pharmaceut market
true custom along chain busi
provid health benefit consum provid
health benefit make almost decis regard drug
pharmaci access busi also sourc suppli
drug partnership togeth b-to-b market
develop use drug health insur
base treat medic ailment consum demand
cash pay market estim less
prescript paid consum directli cash-
pay basi without insur dynam would take
mani consumer-bas compani built
core-compet get involv
pharmaceut space
price pharmaceut
drug price high-profil issu engulf
pharmaceut space percept new
entrant particular amazon instantli enter space
cut price drug product howev actual
price drug alreadi low given massiv amount
buy power pbm drug wholesal retail
pharmaci accumul new entrant would hold
minuscul amount purchas power compar
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
massiv joint sourc ventur
develop last hand year thu level
gener drug discount brand drug rebat new
entrant could command would pale comparison
major pharma supply-chain player make difficult
price competit
access global suppli drug requir
viabl player within pbm pharma wholes
retail pharmaci space access everi legitim drug
requir due variabl demand health
insur product viabl pharma player need abl
access plethora drug
manufactur across world level access
achiev major drug market servic player
new entrant reach level
option clear major drug benefit provid
seller purchas pharmaceut
detail analysi competit dynam
pharmaceut space amazon podeti disrupt
pleas see report sell drug easier said done
moati pharma channel
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
